Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Post by lifeisbutadreamon Apr 13, 2020 10:00pm

196 Views

Post# 30905789

Godmother can't time anything!!..hehehehe.

If this heads into the 0.60,s or 0.70,s tomorrow godmother i will be thinking of your stupidity of your selling shares today that you so conveniently posted...she does that to soft bash and when she sells all she goes into full on bash mode...What a BOZO!..its easy to see the games you play godmother..pretty pathetic behaviour even for you!

Bullboard Posts

Rich TV Live's Stocks to Watch this week (Nov. 8, 2024)